Skip to main content
. 2019 Oct 1;8(10):1565. doi: 10.3390/jcm8101565

Figure 3.

Figure 3

Lower healthcare utilization in adults with sickle cell disease after allogeneic hematopoietic stem cell transplantation from (A) the National Institutes of Health and (B) the University of Illinois at Chicago cohorts, using an alemtuzumab and total body irradiation conditioning regimen.